Literature DB >> 476628

Effect of phorbol ester tumor promoters on the expression of melanogenesis in B-16 melanoma cells.

R A Mufson, P B Fisher, I B Weinstein.   

Abstract

Cells of the C3 clone of B-16 melanoma synthesize melanin only at confluence after which they senesce and can no longer be passaged. Addition to the cultures of 10(-8)--10(-7) M 12-O-tetradecanoylphorbol-13-acetate (TPA) shortly after plating delayed by about 2 days the onset of melanogenesis. TPA did not, however, affect the growth of the cells or the time at which they reached confluence. The ability of a series of phorbol esters to delay melanogenesis correlated with their tumor-promoting activity on mouse skin. The optimum time for addition of TPA was within the first 24 hr after plating; the inhibitory effect decreased when TPA was added at later points. alpha-melanocyte-stimulating hormone (5 x 10(-7) M) added to B-16 cultures 24 hr after plating slowed the growth of the cells and caused them to differentiate when still subconfluent. TPA also inhibited this alpha-melanocyte-stimulating hormone-induced melanogenesis. These results suggest that TPA inhibits a very early stage in a stepwise process that leads to the differentiation of these cultures. For reasons that are not apparent, the cells eventually escape from this inhibition. The B-16 melanoma cell culture system may be useful for studying the mechanism by which TPA and related tumor promoters affect cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 476628

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  In vitro modulation of proliferation and melanization of melanoma cells by citrate.

Authors:  V Bhatnagar; A Srirangam; R Abburi
Journal:  Mol Cell Biochem       Date:  1998-10       Impact factor: 3.396

2.  Limitations of the quantitative cytochemical assay of catechol oxidase in melanoma cells.

Authors:  A C Croce; G Bottiroli; E Prosperi; R Supino; P J Stoward
Journal:  Histochem J       Date:  1988-11

3.  Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin.

Authors:  M Eisinger; O Marko
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

4.  Cellular differentiation and neoplasia: characterization of subpopulations of cells that have neoplasia-related growth properties in Syrian hamster embryo cell cultures.

Authors:  S Nakano; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

5.  Opposing effects of interferon produced in bacteria and of tumor promoters on myogenesis in human myoblast cultures.

Authors:  P B Fisher; A F Miranda; L E Babiss; S Pestka; I B Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

6.  Tumor promoter phorbol myristic acetate stimulates immunoglobulin secretion correlated with growth cessation in human B lymphocyte cell lines.

Authors:  P Ralph; T Kishimoto
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

7.  Antagonism between epidermal growth factor and phorbol ester tumor promoters in human breast cancer cells.

Authors:  C K Osborne; B Hamilton; M Nover; J Ziegler
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

8.  Experimental metastasis and differentiation of murine melanoma cells: actions and interactions of factors affecting different intracellular signalling pathways.

Authors:  D C Bennett; A Holmes; L Devlin; I R Hart
Journal:  Clin Exp Metastasis       Date:  1994-11       Impact factor: 5.150

9.  Selective effects of phorbol 12-myristate 13-acetate on myofibrils and 10-nm filaments.

Authors:  J Croop; Y Toyama; A A Dlugosz; H Holtzer
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

10.  The effect of tumor-promoting phorbol diesters on terminal differentiation of cells in culture.

Authors:  J Abrahm; G Rovera
Journal:  Mol Cell Biochem       Date:  1980-08-16       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.